Nous Research confirms $1.5B valuation, launches AI agents for business users
Nous Research has raised $90M Series B at $1.5B valuation, launching AI agents for business users.
Intelligence analysis by Qwen 2.5 (3B)
Nous Research, a startup developing the open source Hermes Agent, has raised $158M and is launching AI agents for businesses.
Nous Research got a lot of money to make AI tools that help big companies do their work better. They're making these tools so companies can use AI without giving up their secrets.
Analysis
{"
Nous Research Background and Funding Round Details":"Nous Research, a startup focused on the open source Hermes Agent, has secured a $90 million Series B round led by Robot Ventures, with participation from Nvidia, Union Square Ventures, Menlo Ventures, Samsung, and 1789 Capital. The total funding raised by the company is now $158 million.","
Revenue and Future Projections":"By mid-September 2026, Nous Research reported annualized revenue of approximately $36 million. The company expects to reach $100 million in annual revenue by the end of 2026.","
Hermes Agent and Market Adoption":"The Hermes Agent, an open source tool, has been cloned more than 24 million times, accounting for roughly 2.5% of global AI token usage. This highlights the tool's popularity among developers and individuals.","
Enterprise Sector Expansion":"The new financing will be used to expand into the enterprise sector with 'Hermes for Businesses,' allowing companies to deploy customized AI agents that can handle multi-step workflows while keeping their data private and secure."}
Key points
- Nous Research raised $90M Series B at $1.5B valuation
- The new funding will be used for enterprise sector expansion
- The company's open source Hermes Agent has been cloned over 24 million times
The new funding could help accelerate the adoption of AI in enterprise settings, potentially leading to more innovative and secure AI solutions for businesses.
If the new AI agents don't meet the needs of businesses or if data privacy concerns arise, it could slow the adoption of AI in enterprise environments.
